-
Type
All -
Tags
All -
Strategic pillar
All -
Beamlines
All -
From Year
All -
To Year
All -
Quarter
2024 - Q1- All
- 2026 - Q4
- 2026 - Q3
- 2026 - Q2
- 2026 - Q1
- 2025 - Q4
- 2025 - Q3
- 2025 - Q2
- 2025 - Q1
- 2024 - Q4
- 2024 - Q3
- 2024 - Q2
- 2024 - Q1
- 2023 - Q4
- 2023 - Q3
- 2023 - Q2
- 2023 - Q1
- 2022 - Q4
- 2022 - Q3
- 2022 - Q2
- 2022 - Q1
- 2021 - Q4
- 2021 - Q3
- 2021 - Q2
- 2021 - Q1
- 2020 - Q4
- 2020 - Q3
- 2020 - Q2
- 2020 - Q1
- 2019 - Q4
- 2019 - Q3
- 2019 - Q2
- 2019 - Q1
- 2018 - Q4
- 2018 - Q3
- 2018 - Q2
- 2018 - Q1
- 2017 - Q4
- 2017 - Q3
- 2017 - Q2
- 2017 - Q1
- 2016 - Q4
- 2016 - Q3
- 2016 - Q2
- 2016 - Q1
- 2015 - Q4
- 2015 - Q3
- 2015 - Q2
- 2015 - Q1
- 2014 - Q4
- 2014 - Q3
- 2014 - Q2
- 2014 - Q1
- 2013 - Q4
- 2013 - Q3
- 2013 - Q2
- 2013 - Q1
- 2012 - Q4
- 2012 - Q3
- 2012 - Q2
- 2012 - Q1
- 2011 - Q4
- 2011 - Q3
- 2011 - Q2
- 2011 - Q1
- 2010 - Q4
- 2010 - Q3
- 2010 - Q2
- 2010 - Q1
- 2009 - Q4
- 2009 - Q3
- 2009 - Q2
- 2009 - Q1
- 2008 - Q4
- 2008 - Q3
- 2008 - Q2
- 2008 - Q1
- 2007 - Q4
- 2007 - Q3
- 2007 - Q2
- 2007 - Q1
- 2006 - Q4
- 2006 - Q3
- 2006 - Q2
- 2006 - Q1
- 2005 - Q4
- 2005 - Q3
- 2005 - Q2
- 2005 - Q1
- 2004 - Q4
- 2004 - Q3
- 2004 - Q2
- 2004 - Q1
- 2003 - Q4
- 2003 - Q3
- 2003 - Q2
- 2003 - Q1
- 2002 - Q4
- 2002 - Q3
- 2002 - Q2
- 2002 - Q1
- 2001 - Q4
- 2001 - Q3
- 2001 - Q2
- 2001 - Q1
| Publication | Beamlines | Type | Strategic Pillar |
|---|---|---|---|
| Hao Li; Helge Eduard Rask-Andersen; Dan Jiang; Gerard Mary O'donoghue; Douglas Edward Hugh Hartley et al. (2024). Method for the treatment of an auditory disease or condition. Patent Number: WO2024052494A1. | Patent | ||
| Kelsey Sivick Gauthier; John Lippincott; Nigel Pelham Clinton Walker; Xiaoning Zhao (2024). Antibodies to tigit. Patent Number: PH12022553257A1. | Patent | ||
| Michael PRAVICA (2024). Polymer compositions. Patent Number: EP3497168B1. | Patent | ||
| 庫丹達拉姆 皮拉瑞斯提; 艾瑞克 鮑德溫; 戈登 包爾斯; 羅沙 卡多索; 里卡多 阿塔爾 et al. (2024). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: TW202406935A. | Patent |